IntraLuminal Therapeutics Inc.
This article was originally published in Start Up
Executive Summary
IntraLuminal Therapeutics is developing a new guidance system designed to help interventional cardiologists safely cross total occlusions.
You may also be interested in...
FlowCardia: Playing it Safe in Total Occlusions
Chronic total occlusions remain one of the most significant challenges and opportunities facing interventional cardiologists and radiologists. FlowCardia is looking to succeed where other device companies have failed by emphasizing safety and simplicity.
FlowCardia: Playing it Safe in Total Occlusions
Chronic total occlusions remain one of the most significant challenges and opportunities facing interventional cardiologists and radiologists. FlowCardia is looking to succeed where other device companies have failed by emphasizing safety and simplicity.
Total Occlusions: Device Obstacle or Opportunity?
The market is promising for using catheters, instead of surgery, to open vascular blockages. But the right technology remains elusive.